ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,334Top JournalHybrid

Radiotherapy and Oncology

Acronym:radonc
•
Abbreviation (ISO):RADIOTHER ONCOL
•
Identifier (ISSN):0167-8140(Print)/1879-0887(Online)
•
Publisher:Elsevier Ireland Ltd
Clarivate IF (2026)
5.8↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Radiotherapy and Oncology

WoS Q1
35794.9420185.2520194.8620206.2820216.920225.720234.920245.320255.82026
Annual Impact Factor Metric
Current (2026):5.8
Scopus SJR & RankScopus Q1
2.076
#1,334

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
196

196 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate10.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
415articles/year
38.06% Gold OA•88.89% Original Research

Aims & Scope

Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.

Topics Covered (Recognized by AI)
Medicine91.1%Internal medicine71.7%Radiology60.6%Surgery57.6%Biology56.3%Radiation therapy50.3%Physics46%Genetics45%Cancer35.3%Nuclear medicine33.2%Oncology31.3%Computer science25.7%Medical physics24.5%Pathology22.6%Chemistry20.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank67/333
IndexSCIE
JCRSCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q1
Rank23/217
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank52/333
IndexSCIE
JCISCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q1
Rank27/217
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.8
Articles / Year506
Total Citations129
2025
IF5.3
Articles / Year3,473
Total Citations1,883
2024
IF4.9
Articles / Year3,769
Total Citations4,253
2023
IF5.7
Articles / Year3,073
Total Citations6,825
2022
IF6.901
Articles / Year2,433
Total Citations7,248

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,334Scopus Q1SCImago Profile
Scopus Coverage:1983-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
2.076

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.97

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,733 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations6,121
3-Year Documents1,195
Citable Documents1,034

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1
OncologyQ1
Radiology, Nuclear Medicine and ImagingQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 10.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Radiotherapy and Oncology (acronym: radonc, abbr: RADIOTHER ONCOL, ISSN: 0167-8140) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ireland Ltd in Netherlands since 1983. The periodical holds a Journal Impact Factor (JIF) of 5.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.076 (Q1), an H-index of 196.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 415 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,733 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ireland Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1983
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5abf42c8-b94d-4818-a75c-27062d97c27f
Database Updated: 2026-10-16